154 related articles for article (PubMed ID: 6539648)
1. Acquisition of multiple drug resistance by CCRF-CEM cells selected for different degrees of resistance to vincristine.
Conter V; Beck WT
Cancer Treat Rep; 1984 Jun; 68(6):831-9. PubMed ID: 6539648
[TBL] [Abstract][Full Text] [Related]
2. Reversal of Vinca alkaloid resistance but not multiple drug resistance in human leukemic cells by verapamil.
Beck WT; Cirtain MC; Look AT; Ashmun RA
Cancer Res; 1986 Feb; 46(2):778-84. PubMed ID: 3455678
[TBL] [Abstract][Full Text] [Related]
3. Atypical multidrug resistance in a therapy-induced drug-resistant human leukemia cell line (LALW-2): resistance to Vinca alkaloids independent of P-glycoprotein.
Haber M; Norris MD; Kavallaris M; Bell DR; Davey RA; White L; Stewart BW
Cancer Res; 1989 Oct; 49(19):5281-7. PubMed ID: 2569932
[TBL] [Abstract][Full Text] [Related]
4. Verapamil reversal of vincristine resistance and cross-resistance patterns of vincristine-resistant Chinese hamster ovary cells.
Brewer F; Warr JR
Cancer Treat Rep; 1987 Apr; 71(4):353-9. PubMed ID: 2881620
[TBL] [Abstract][Full Text] [Related]
5. Cross-resistance of cultured murine leukemia vincristine-resistant P388 cells to vinblastine, vindesine, and bis (N-ethylidene vindesine) disulfide, disulfate.
Wilkoff LJ; Dulmadge EA
J Natl Cancer Inst; 1982 Jun; 68(6):1023-6. PubMed ID: 6953266
[TBL] [Abstract][Full Text] [Related]
6. Augmentation of 1-beta-D-arabinofuranosylcytosine resistance in human KB epidermoid carcinoma cells upon induction of a second resistance to vincristine.
Sone S; Ishii K; Tsuruo T
Cancer Res; 1986 Jun; 46(6):3099-104. PubMed ID: 3698026
[TBL] [Abstract][Full Text] [Related]
7. Atypical multiple drug resistance in a human leukemic cell line selected for resistance to teniposide (VM-26).
Danks MK; Yalowich JC; Beck WT
Cancer Res; 1987 Mar; 47(5):1297-301. PubMed ID: 3469013
[TBL] [Abstract][Full Text] [Related]
8. Cross-resistance of vinblastine- and taxol-resistant mutants of Chinese hamster ovary cells to other anticancer drugs.
Gupta RS
Cancer Treat Rep; 1985 May; 69(5):515-21. PubMed ID: 2860971
[TBL] [Abstract][Full Text] [Related]
9. Establishment and properties of vincristine-resistant human myelogenous leukemia K562.
Tsuruo T; Iida H; Ohkochi E; Tsukagoshi S; Sakurai Y
Gan; 1983 Oct; 74(5):751-8. PubMed ID: 6580255
[TBL] [Abstract][Full Text] [Related]
10. Circumvention of vincristine and Adriamycin resistance in vitro and in vivo by calcium influx blockers.
Tsuruo T; Iida H; Nojiri M; Tsukagoshi S; Sakurai Y
Cancer Res; 1983 Jun; 43(6):2905-10. PubMed ID: 6850602
[TBL] [Abstract][Full Text] [Related]
11. Acquired vs innate multidrug resistance and the effect of calcium channel blockers.
Tsuruo T
Prog Clin Biol Res; 1986; 223():203-16. PubMed ID: 3468516
[TBL] [Abstract][Full Text] [Related]
12. Direct interaction between verapamil and doxorubicin causes the lack of reversal effect of verapamil on P-glycoprotein mediated resistance to doxorubicin in vitro using L1210/VCR cells.
Breier A; Drobná Z; BarancĂk M
Neoplasma; 1998; 45(4):248-53. PubMed ID: 9890669
[TBL] [Abstract][Full Text] [Related]
13. Glutathione S-transferase M1 and multidrug resistance protein 1 act in synergy to protect melanoma cells from vincristine effects.
Depeille P; Cuq P; Mary S; Passagne I; Evrard A; Cupissol D; Vian L
Mol Pharmacol; 2004 Apr; 65(4):897-905. PubMed ID: 15044619
[TBL] [Abstract][Full Text] [Related]
14. STI571 combined with vincristine greatly suppressed the tumor formation of multidrug-resistant K562 cells in a human-nude mice xenograft model.
Gao L; Chen L; Fei XH; Qiu HY; Zhou H; Wang JM
Chin Med J (Engl); 2006 Jun; 119(11):911-8. PubMed ID: 16780770
[TBL] [Abstract][Full Text] [Related]
15. Cross-resistance to diverse drugs is associated with primary cisplatin resistance in ovarian cancer cell lines.
Hamaguchi K; Godwin AK; Yakushiji M; O'Dwyer PJ; Ozols RF; Hamilton TC
Cancer Res; 1993 Nov; 53(21):5225-32. PubMed ID: 8106143
[TBL] [Abstract][Full Text] [Related]
16. Reciprocal cross-resistance in human rhabdomyosarcomas selected in vivo for primary resistance to vincristine and L-phenylalanine mustard.
Horton JK; Houghton PJ; Houghton JA
Cancer Res; 1987 Dec; 47(23):6288-93. PubMed ID: 2890432
[TBL] [Abstract][Full Text] [Related]
17. Verapamil-mediated sensitization of doxorubicin-selected pleiotropic resistance in human sarcoma cells: selectivity for drugs which produce DNA scission.
Harker WG; Bauer D; Etiz BB; Newman RA; Sikic BI
Cancer Res; 1986 May; 46(5):2369-73. PubMed ID: 3754487
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of action of E7010, an orally active sulfonamide antitumor agent: inhibition of mitosis by binding to the colchicine site of tubulin.
Yoshimatsu K; Yamaguchi A; Yoshino H; Koyanagi N; Kitoh K
Cancer Res; 1997 Aug; 57(15):3208-13. PubMed ID: 9242451
[TBL] [Abstract][Full Text] [Related]
19. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K
Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
[TBL] [Abstract][Full Text] [Related]
20. [MDR-reversing effect of short peptide binding specifically to multidrug-resistant gastric cancer cells].
Wang P; Ding J; Lin T; Han S; Cao SS; Ge FL; An GQ; Li R; Lei T; Bai FH; Fan DM
Zhonghua Zhong Liu Za Zhi; 2007 Apr; 29(4):258-61. PubMed ID: 17760250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]